| Q39659332 | Actinomycin D synergistically enhances the efficacy of the BH3 mimetic ABT-737 by downregulating Mcl-1 expression |
| Q37799220 | Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents? |
| Q35149637 | Classification of current anticancer immunotherapies |
| Q42553556 | Consensus guidelines for the detection of immunogenic cell death |
| Q30499197 | DNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunity |
| Q47161842 | Eco-Friendly Formulated Zinc Oxide Nanoparticles: Induction of Cell Cycle Arrest and Apoptosis in the MCF-7 Cancer Cell Line |
| Q39277487 | Ferroptosis: bug or feature? |
| Q24339614 | Human ALKBH7 is required for alkylation and oxidation-induced programmed necrosis |
| Q37584300 | Intermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression |
| Q92020287 | Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis |
| Q36101917 | Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators |
| Q55463679 | Necroptosis: A novel therapeutic target for glioblastoma |
| Q41833885 | Non-apoptotic routes to defeat cancer |
| Q39581383 | Oxidatively activated DNA-modifying agents for selective cytotoxicity |
| Q36246486 | Proteasomal inhibition sensitizes cervical cancer cells to mitomycin C-induced bystander effect: the role of tumor microenvironment. |
| Q39541493 | Squamous cell carcinoma antigen 1 promotes caspase-8-mediated apoptosis in response to endoplasmic reticulum stress while inhibiting necrosis induced by lysosomal injury |
| Q35684572 | The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells |
| Q34317015 | The class IA phosphatidylinositol 3-kinase p110-β subunit is a positive regulator of autophagy |
| Q38437281 | The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy. |
| Q34786538 | The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells |
| Q21133813 | Titanium dioxide (TiO2) nanoparticles preferentially induce cell death in transformed cells in a Bak/Bax-independent fashion |
| Q35624661 | Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts |
| Q39413633 | VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression. |